This inventor holds 1 USPTO granted patent. Top assignee: Seoul National University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Hyeonkyeong Kim: Innovator in Chondrosarcoma Treatment
Introduction
Hyeonkyeong Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in the treatment of chondrosarcoma, a type of bone cancer. His innovative approach focuses on the regulation of HIF-2α, which plays a crucial role in the development and metastasis of this disease.
Latest Patents
Hyeonkyeong Kim holds a patent for the use of HIF-2α inhibitors for treating chondrosarcoma or preventing its recurrence and metastasis. The patent outlines a method that effectively treats chondrosarcoma by inhibiting HIF-2α during its development and spread, especially in cases of dedifferentiated chondrosarcoma. This breakthrough has the potential to improve patient outcomes significantly.
Career Highlights
Hyeonkyeong Kim is affiliated with Seoul National University, where he conducts his research and develops innovative treatment methods. His work has garnered attention in the medical community, highlighting his commitment to advancing cancer treatment.
Collaborations
Hyeonkyeong Kim has collaborated with notable colleagues, including Jin-Hong Kim and Hyeon-Seop Kim. These partnerships have contributed to the development of effective strategies in cancer research and treatment.
Conclusion
Hyeonkyeong Kim's contributions to the field of chondrosarcoma treatment through his innovative patent demonstrate his dedication to improving cancer therapies. His work continues to inspire advancements in medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile